Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pharmanex Switching To Direct Sales Following Acquisition By Nu Skin

This article was originally published in The Tan Sheet

Executive Summary

Starting Jan. 15, Cholestin marketer Pharmanex will offer its dietary supplements through direct marketing channels, using the sales network of its new parent company, Nu Skin Enterprises. The plan to switch to direct sales, which Pharmanex announced Nov. 18, will involve withdrawing its products from all mass market retail outlets, totaling approximately 30,000 stores.

You may also be interested in...



Pharmanex Cholestin Bar For Healthy Cholesterol Levels Launching

Pharmanex is introducing a line extension to its Cholestin cholesterol-lowering supplement - a bar with the same red yeast rice formula - the firm announced Oct. 25.

Pharmanex Cholestin Bar For Healthy Cholesterol Levels Launching

Pharmanex is introducing a line extension to its Cholestin cholesterol-lowering supplement - a bar with the same red yeast rice formula - the firm announced Oct. 25.

Pharmanex Cholestin Bar For Healthy Cholesterol Levels Launching

Pharmanex is introducing a line extension to its Cholestin cholesterol-lowering supplement - a bar with the same red yeast rice formula - the firm announced Oct. 25.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS089111

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel